Engaging Native Hawaiian/Pacific Islanders and Activating Communities to Take Steps (ENACTS)

Sponsor
Washington State University (Other)
Overall Status
Recruiting
CT.gov ID
NCT03484364
Collaborator
(none)
270
1
2
60.4
4.5

Study Details

Study Description

Brief Summary

Our Specific Aims are:
  1. At the individual level, to compare within-person change in BP and secondary outcomes between the intervention and control groups.

  2. At the family level, to evaluate ENACTS' effects on BP and secondary outcomes as within-person change in family members who provide primary support, and as mean change in other adult family members who are not directly engaged in the intervention.

  3. At the policy level, to evaluate the intervention's ability to influence grocery store policy on clearly identifying foods that are low in sodium or high in potassium, some of which might not be easily identified with existing labels (e.g., fresh produce). ENACTS combines empirically supported elements of existing programs, thus increasing its probability of success. It aligns with the American Heart Association's call for multilevel prevention.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: ENACTS
N/A

Detailed Description

This study adapts an existing educational intervention to address self-management of hypertension in NHPIs. The multilevel 6-month intervention - "Engaging NHPIs and Activating Communities to Take Steps" (ENACTS) - will use peer-facilitated, self-care BP education delivered weekly for 8 weeks emphasizing healthy diet, traditional NHPI foods, adherence to medication, and encouragement to increase physical activity and stop smoking; with text messaging to boost adherence. ENACTS will be implemented as a randomized controlled trial at 3 community sites serving NHPIs in the Puget Sound area of Washington. 270 NHPI adults (90 per site) with a self-reported physician diagnosis of hypertension and elevated BP measured at enrollment will be randomized to either ENACTS or usual care.

The primary outcome is change in systolic BP. Secondary outcomes are food purchasing behaviors (online ordering, grocery receipts); medication adherence; social support; smoking cessation; and GIS data on daily energy expenditure. The study will use a Geographic Information Systems (GIS) mobile phone app to track participants. Outcomes will be measured at baseline, weekly, at 8 weeks, and at 6 months. The study will also examine change in household food purchasing patterns, enhanced family support for BP control, and BP improvement among family members. A subset of intervention participants and family members will be invited to participate in a program that uses personal photographs for narrative art projects to promote labeling of healthy foods by local retail outlets.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
270 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Engaging Native Hawaiian/Pacific Islanders and Activating Communities to Take Steps (ENACTS)
Actual Study Start Date :
Jun 15, 2018
Anticipated Primary Completion Date :
Feb 28, 2023
Anticipated Study Completion Date :
Jun 28, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention Group

The ENACTS intervention is four peer-facilitated educational classes delivered over 8 weeks focused on hypertension self-management.

Behavioral: ENACTS
Peer-facilitated, self-care BP education delivered every other week for 8 weeks emphasizing healthy diet, traditional NHPI foods, adherence to medication, and encouragement to increase physical activity and stop smoking, with text messaging to boost adherence. $50 of groceries every other week (4 times) over 8 weeks.
Other Names:
  • Healthy Hearts Among Pacific Islanders (HHAPI)
  • No Intervention: Waitlist Group

    Usual care and $50 in groceries every other week for 8 weeks.

    Outcome Measures

    Primary Outcome Measures

    1. Systolic Blood Pressure [6 months]

      Automatic blood pressure

    Secondary Outcome Measures

    1. Eating Behaviors [6 months]

      24 hour dietary recall

    2. Food Purchasing [6 months]

      Grocery receipts

    3. Medication Adherence [6 months]

      Hill Bone High Blood Pressure Compliance Scale

    4. Social Support [6 months]

      Family care climate questionnaire

    5. Tobacco Use [6 months]

      National Health Interview Survey

    6. Daily Energy Expenditure [6 months]

      International Physical Activity Questionnaire (IPAQ)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Self-reported physician diagnosis of hypertension and/or type 2 diabetes confirmed by a prescription for an anti-hypertensive medication and/or type 2 diabetes medication;

    • Self-reported NHPI race;

    • *Age 18 years and older at enrollment;

    • Measured systolic BP ≥ 140 mmHg on enrollment; measured baseline fasting glucose >125

    • reliable internet access

    • computer or Smartphone

    • current email address

    • *Ability to understand written and spoken English; and

    • *Ability and willingness to follow all study protocols.

    Exclusion Criteria:
    • Pregnant or planning on becoming pregnant throughout the course of the study;

    • Currently undergoing dialysis or treatment for a terminal illness;

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 National Recruitment via Facebook and Internet Seattle Washington United States 98101

    Sponsors and Collaborators

    • Washington State University

    Investigators

    • Principal Investigator: Ka'imi A Sinclair, PhD, MPH, Washington State University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Ka'imi Sinclair, Associate Professor, Washington State University
    ClinicalTrials.gov Identifier:
    NCT03484364
    Other Study ID Numbers:
    • U54MD011240 127687
    • U54MD011240
    First Posted:
    Mar 30, 2018
    Last Update Posted:
    Mar 11, 2022
    Last Verified:
    Feb 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 11, 2022